Search

Author/Creator Bulvik, Shlomo

1. A novel potential therapy for vascular diseases: blood‐derived stem/progenitor cells specifically activated by dendritic cells. Issue 7 (October 2014)

Authors:
Porat, Yael; Assa‐Kunik, Efrat; Belkin, Michael; Krakovsky, Michael; Lamensdorf, Itschak; Duvdevani, Revital; Sivak, Galit; Niven, Mark J.; Bulvik, Shlomo
Journal:
Diabetes/metabolism research and reviews
Issue:
Volume 30:Issue 7(2014:Oct.)
Page Start:
623
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long‐term follow‐up of a multi‐center prospective study. Issue 1 (17th October 2019)

Authors:
Ofran, Yishai; Hayun, Michal; Leiba, Ronit; Zuckerman, Tsila; Horowitz, Netanel; Hoffman, Ron; Ringelstein, Shimrit; Lavi, Noa; Frisch, Avraham; Henig, Israel; Gatt, Moshe E.; Hellmann, Ilana; Arad, Ariela; Bulvik, Shlomo; Ram, Ron; Gino‐Moor, Sharon; Saban, Revital; Tvito, Ariella; Rowe, Jacob M...
Journal:
American journal of hematology
Issue:
Volume 95:Issue 1(2020:Jan.)
Page Start:
E3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Primary plasma cell leukemia in the era of novel agents for myeloma – a multicenter retrospective analysis of outcome. (May 2018)

Authors:
Ganzel, Chezi; Rouvio, Ory; Avivi, Irit; Magen, Hila; Jarchowsky, Osnat; Herzog, Katrin; Cohen, Yossi; Tadmor, Tamar; Horwitz, Netanel A.; Leiba, Merav; Nagler, Arnon; Cohen, Yael; Bulvik, Shlomo; Polliack, Aaron; Rowe, Jacob M.; Gatt, Moshe E.
Journal:
Leukemia research
Issue:
Volume 68(2018)
Page Start:
9
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemia. Issue 12 (17th November 2015)

Authors:
Ofran, Yishai; Leiba, Ronit; Ganzel, Chezi; Saban, Revital; Gatt, Moshe; Ram, Ron; Arad, Ariela; Bulvik, Shlomo; Hellmann, Ilana; Gino‐Moor, Sharon; Zuckerman, Tsila; Hoffman, Ron; Horowitz, Netanel; Lavi, Noa; Ringelstein, Shimrit; Henig, Israel; Hayun, Michal; Rowe, Jacob M.
Journal:
American journal of hematology
Issue:
Volume 90:Issue 12(2015:Dec.)
Page Start:
1159
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practice. Issue 11 (November 2015)

Authors:
Ellis, Martin H.; Lavi, Noa; Mishchenko, Elena; Dally, Najib; Lavie, David; Courevitch, Anna; Gutwein, Odit; Bulvik, Shlomo; Braester, Andrei; Chubar, Evgeni; Tavor, Sigal; Duek, Adrian; Kirgner, Ilya; Koren-Michowitz, Maya
Journal:
Leukemia research
Issue:
Volume 39:Issue 11(2015:Nov.)
Page Start:
1154
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗